Research on gut inflammation in pediatric patients with inflammatory bowel diseases
Official title: Seattle Spatial Transcriptomic Research in Inflammatory Bowel Disease Evaluation
Run by Seattle Children's Hospital · NCT06315179 · Data updated 2026-11-12
This study is trying to learn more about gut inflammation in kids with inflammatory bowel diseases by collecting health information and samples from them and comparing it to kids who have different gut issues but no inflammation.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 6 Years to 21 Years |
| Sex | All |
| Enrollment | 200 (estimated) |
| Sponsor | Seattle Children's Hospital Academic / other |
| Locations | 1 site (Seattle, Washington) |
| Status | Recruiting |
| Started | May 10, 2024 |
| Main results expected | January 2028 |
| Study ends | January 2030 |
| Registry record updated | April 24, 2026 |
| Trial ID | NCT06315179 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are pediatric patients suspected of having Crohn's disease, ulcerative colitis, or indeterminate colitis.
✕Probably not a fit
Patients with other serious medical conditions or those who are pregnant may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study aims to collect long-term clinical data and biological samples from pediatric patients diagnosed with inflammatory bowel diseases (IBD), including Crohn's disease and ulcerative colitis. It will also include a control group of pediatric patients with disorders of brain-gut interactions who do not have detectable gut inflammation. Participants will undergo standard clinical evaluations, during which blood, stool, and tissue samples will be collected as needed. Additionally, urine samples will be collected specifically for research purposes during clinical visits.
Why it matters
Potential benefit: If successful, this research could enhance understanding of inflammatory bowel diseases and improve treatment strategies for affected pediatric patients.
How similar studies have gone: Other studies have shown promise in understanding inflammatory bowel diseases through similar observational approaches, indicating potential for success.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Suspected diagnosis of CD (Crohn's Disease), UC (Ulcerative Colitis) or Indeterminate colitis (IC) Exclusion Criteria: * Evidence of Other Complicating Medical Issues: * Other serious medical conditions, such as neurological, liver, kidney, or systemic disease * Pregnancy * Tobacco, alcohol, or illicit drug abuse
Where it's running
-
Seattle Children's Hospital
Seattle, Washington, United States Recruiting
Study contacts
- Principal investigator: Betty (Hengqi) Zheng, MD — Seattle Children's Hospital, University of Washington
- Study coordinator: Mason E Nuding, BS
- Email: mason.nuding@seattlechildrens.org
- Phone: 206-987-0055
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Self-management program to improve health in inflammatory bowel disease
A digital self-management program is being tested to see if it helps people with inflammatory bowel disease feel better and manage their symptoms alongside standard care.
-
Observational study comparing inflammatory markers in IBD and non-IBD participants
This study is trying to see how inflammation levels in people with Crohn's Disease and Ulcerative Colitis compare to those without these conditions when they start new treatments.
-
Evaluating robotic surgery for inflammatory bowel disease
This study is testing if robotic surgery can be a good option for adults with inflammatory bowel disease, like Crohn's or ulcerative colitis, compared to traditional surgery methods.
-
How nutrition and body composition relate to outcomes in people with IBD
This study will see if nutrition and muscle mass affect outcomes in people with Crohn's disease or ulcerative colitis who are starting advanced medicines or having IBD-related surgery.
-
Switching to subcutaneous infliximab for IBD treatment
This study is testing if switching people with inflammatory bowel disease from an intravenous form of infliximab to a subcutaneous version, given weekly or bi-weekly, can lead to better health results.
-
Analyzing genetic factors in inflammatory bowel disease across different populations
This study is trying to find out how genes and the environment affect inflammatory bowel disease by looking at samples from people with the condition and healthy individuals.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.